UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination

PloS one, 2021-08, Vol.16 (8), p.e0256155-e0256155

2021

Volltextzugriff (PDF)

Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis

Scientific reports, 2021-03, Vol.11 (1), p.7174-16, Article 7174

2021

Volltextzugriff (PDF)

BCG vaccination and multiple sclerosis risk: A Norwegian cohort study

Multiple sclerosis, 2024-05, Vol.30 (6), p.646-653

2024

Volltextzugriff (PDF)

Effects of vitamin D on axonal damage during de- and remyelination in the cuprizone model

Journal of neuroimmunology, 2018-08, Vol.321, p.61-65

2018

Volltextzugriff (PDF)

The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination

PloS one, 2023-11, Vol.18 (11), p.e0293908-e0293908

2023

Volltextzugriff (PDF)

An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis

ASN neuro, 2023-01, Vol.15, p.17590914231198980-17590914231198980

2023

Volltextzugriff (PDF)

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model

PloS one, 2011-10, Vol.6 (10), p.e26262

2011

Volltextzugriff (PDF)

Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model

PloS one, 2013-12, Vol.8 (12), p.e84162

2013

Volltextzugriff (PDF)

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients

Multiple sclerosis, 2019-06, Vol.25 (7), p.987-993

2019

Volltextzugriff (PDF)

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study

Multiple sclerosis journal - experimental, translational and clinical, 2021-01, Vol.7 (1), p.2055217320973049-2055217320973049

2021

Volltextzugriff (PDF)

Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis

Multiple sclerosis journal - experimental, translational and clinical, 2021-04, Vol.7 (2), p.20552173211022027-20552173211022027

2021

Volltextzugriff (PDF)

The cuprizone model: regional heterogeneity of pathology

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2012-08, Vol.120 (8), p.648-657

2012

Volltextzugriff (PDF)

Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity

PloS one, 2013-09, Vol.8 (9), p.e75021-e75021

2013

Volltextzugriff (PDF)

Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction

PloS one, 2013-01, Vol.8 (1), p.e54417

2013

Volltextzugriff (PDF)

Treatment Persistence of Cladribine Tablets Versus Other Oral Disease-modifying Treatments for Multiple Sclerosis: Results from Danish, Norwegian, and Swedish Registries (P10-6.015)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Safety of breast feeding during rituximab treatment in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2022-07, Vol.94 (1), p.38-41

2022

Volltextzugriff (PDF)

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations

Journal of neurology, neurosurgery and psychiatry, 2023-01, Vol.94 (1), p.19-22

2023

Volltextzugriff (PDF)

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

Journal of neurology, neurosurgery and psychiatry, 2016-02, Vol.87 (2), p.126-129

2016

Volltextzugriff (PDF)

Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model

Journal of neuroimmunology, 2020-02, Vol.339, p.577091-577091, Article 577091

2020

Volltextzugriff (PDF)

Long-term Survival in Multiple Sclerosis is Improving (P5-3.011)

Neurology, 2023, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

En ung kvinne med langvarig kvalme, oppkast og hikke

Tidsskrift for den Norske Lægeforening, 2021

2021

Volltextzugriff (PDF)

Neurofilament light chain predicts disease activity in relapsing-remitting MS

Neurology : neuroimmunology & neuroinflammation, 2018-01, Vol.5 (1), p.e422-e422

2018

Volltextzugriff (PDF)

The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis

Current medical research and opinion, 2023-10, Vol.39 (10), p.1367-1374

2023

Volltextzugriff (PDF)

Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study

Neurology, 2021-06, Vol.96 (23), p.e2789

2021

Volltextzugriff (PDF)

Breastfeeding and treatment for multiple sclerosis

Tidsskrift for den Norske Lægeforening, 2022-10

2022

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(59)
Tagungsberichte
(1)

Sprache

Englisch
(57)
Norwegisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination

Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis

BCG vaccination and multiple sclerosis risk: A Norwegian cohort study

Effects of vitamin D on axonal damage during de- and remyelination in the cuprizone model

The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination

An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model

Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study

Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis

The cuprizone model: regional heterogeneity of pathology

Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity

Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction

Treatment Persistence of Cladribine Tablets Versus Other Oral Disease-modifying Treatments for Multiple Sclerosis: Results from Danish, Norwegian, and Swedish Registries (P10-6.015)

Safety of breast feeding during rituximab treatment in multiple sclerosis

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model

Long-term Survival in Multiple Sclerosis is Improving (P5-3.011)

En ung kvinne med langvarig kvalme, oppkast og hikke

Neurofilament light chain predicts disease activity in relapsing-remitting MS

The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis

Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study

Breastfeeding and treatment for multiple sclerosis

Suchergebnisse filtern